Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Finding a clue to the origin of treatment-resistant leukemia in kids

2.

Could semaglutide be used to treat addiction in addition to obesity?

3.

GLP-1 receptor agonists show anti-cancer benefits beyond weight loss

4.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

5.

Alternative breast imaging techniques beyond mammography.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot